How effective is Risperdal for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 3.1/5
This is a phase IV clinical study of how effective Risperdal (risperidone) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 24 Risperdal users and is updated continuously.
What is Risperdal?
Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 610 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
24 people are studied for taking Risperdal in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Risperdal effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 4
- somewhat: 1
- moderate: 12
- high: 6
- very high: 1
Long Term:
- not at all: 2
- somewhat: 1
- moderate: 5
- high: 5
- very high: 1
Gender of people who take Risperdal for Attention deficit hyperactivity disorder *:
- female: 16.67 %
- male: 83.33 %
Age of people who take Risperdal for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 33.33 %
- 10-19: 45.83 %
- 20-29: 8.33 %
- 30-39: 4.17 %
- 40-49: 8.33 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Risperdal more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Risperdal for Attention deficit hyperactivity disorder *:
- female: 0.0 %
- male: 100 %
Age of people who take Risperdal for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 14.29 %
- 10-19: 57.14 %
- 20-29: 14.29 %
- 30-39: 14.29 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Risperdal?
- You can start a phase IV clinical trial to monitor Risperdal safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Risperdal (127,729 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,330 reports)
How the study uses the data?
The study is based on risperidone (the active ingredients of Risperdal) and Risperdal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cytoxan cause Wrist Fracture? - 7 seconds ago
- Could Xanax cause Eyelid Twitch? - 10 seconds ago
- Could Lamictal cause Bedwetting? - 11 seconds ago
- Could Lyrica cause Liver Function Test Abnormal? - 25 seconds ago
- Could Ursodeoxycholic Acid cause Ileitis Aggravated? - 29 seconds ago
- Drug interactions of Clindamycin Hydrochloride and Trimethoprim - 31 seconds ago
- Lo Loestrin Fe vs. Altavera, side effect and effectiveness comparison - 32 seconds ago
- Drug interactions of Imatinib Mesylate and Vitamin C - 38 seconds ago
- Could Doxycycline cause Conjunctivitis Aggravated? - 43 seconds ago
- Could Nicotine Polacrilex cause Rashes? - 44 seconds ago